Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 665-672

  Ishikawa, Yukio ^a   Akasaka, Yoshikiyo ^a   Ishii, Toshiharu ^a   Komiyama, Kazuo ^b   Masuda, Shigeru ^c   Asuwa, Noriko ^c   Choi Miura, Nam Ho ^d   Tomita, Motowo ^d  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d SHOWA UNIVERSITY   (Japan)

Author keywords

Apolipoprotein J; Apolipoproteins; Atherosclerosis; Human aorta; In situ hybridization

Indexed keywords

CLUSTERIN;

AORTA ATHEROSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0031976656     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.665     Document Type: Article

References (20)

1. Witte DP, Aronow BJ, Staudeman ML, Stuart WD, Clay MA, Gruppo RA, Jenkins SH, Harmony JAK. Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol. 1993;143:763-773.
2. Jenne DE, Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfate glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA. 1989;86:7123-7127.
3. Watts MJ, Dankert JR, Morgan P. Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids. Biochem J. 1990;265:471-477.
4. de Silva HV, Harmony LAK, Stuart WD, Gil CM, Robbins J. Apolipoprotein J: structure and tissue distribution. Biochemistry. 1990;29:5380-5389.
5. Zannis VI, Cole FS, Jackson CL, Kurnit DM, Karathanasis SK. Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues: time dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry. 1985;24:4450-4455.
6. Lin-Lee YC, Kao FT, Cheung P, Chan L. Apolipoprotein E gene mapping and expression: localization of structural gene to human chromosome 19 and expression of apoE mRNA in lipoprotein- and non-lipoprotein-producing tissues. Biochemistry. 1985;24:3751-3756.
7. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA. 1985;82:203-207.
8. Murphy BF, Daves DJ, Morrow W, d'Apice AJF. Localization of terminal complement components, S-protein and SP-40,40 in renal biopsies. Pathology. 1989;21:275-278.
9. Aronow BJ, Lund SD, Brown TL, Harmony JAK. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA. 1993;90:725-729.
10. Jenne DE, Lowin B, Peitsch MC, Bottcher A, Schmitz G, Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem. 1991;266:11030-11036.
11. de Silva HV, Stuart WD, Duvic CR, Wetterau JR, Ray MJ, Ferguson DG, Albers HW, Smith WR, Harmony JAK. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem. 1990;265:13240-13247.
12. Jordan-Starck TC, Lund SD, Witte DP, Aronow BJ, Ley GA, Stuart WD, Swertfeger DK, Clayton LR, Sells SF, Paigen B, Harmony JAK. Mouse apolipoprotein J: characterization of a gene implicated in atherosclerosis. J Lipid Res. 1994;35:194-210.
13. Mackness B, Hunt R, Durrington PN, Mackness MI. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:1233-1238.
14. Tobe T, Minoshima S, Yamane S, Choi N-H, Tomita M, Shimizu N. Assignment of a human serum glycoprotein SP-40,40 gene (CLI) to chromosome 8. Cytogenet Cell Genet. 1991;57:193-195.
15. Choi NH, Nakano Y, Tobe T, Mazda T, Tomita M. Incorporation of SP-40,40 into the soluble membrane attack complex (SMAC, SC5b-9) of complement. Int Immunol. 1990;2:413-417.
16. Goldstein JL, Brown MS. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem. 1977;46:897-930.
17. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
18. Brewer HB Jr. Current concepts of the molecular structure and metabolism of human apolipoproteins and lipoproteins. Klin Wochenschr. 1981;59:1023-1035.
19. Scanu AJ, Toth J, Edelstein C, Stiller E. Fractionation of human serum high density lipoprotein in urea solutions: evidence for polypeptide heterogeneity. Biochemistry. 1969;8:3309-3316.
20. Gibson JC, Rubinstein A, Bukberg PR, Brown WV. Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res. 1983;24:886-898.